<?xml version="1.0" encoding="UTF-8"?>
<p id="p0275">Gemcitabine has also shown antibacterial activity against gram-positive bacteria, such as 
 <italic>Enterococcus</italic>, 
 <italic>Listeria</italic>, 
 <italic>Bacillus</italic>, and 
 <italic>Staphylococcus</italic>, including multi-drug-resistant strains of 
 <italic>Staphylococcus aureus</italic> (
 <xref rid="bib99" ref-type="bibr">Thomson and Lamont, 2019</xref>; 
 <xref rid="bib44" ref-type="bibr">Jordheim et al., 2012</xref>; 
 <xref rid="bib86" ref-type="bibr">Sandrini et al., 2007</xref>). Unfortunately, one study revealed that the treated strains developed resistance to gemcitabine. Such a phenomenon could in turn be overcome by the combination of gemcitabine and gentamicin, which showed synergistic activity and reduced the rate of resistance development (
 <xref rid="bib44" ref-type="bibr">Jordheim et al., 2012</xref>). Gemcitabine did not show activity against gram-negative bacteria.
</p>
